Literature DB >> 25502494

A comparison of structural and functional changes in patients screened for hydroxychloroquine retinopathy.

Vivienne C Greenstein1, Luz Amaro-Quireza, Evelyn S Abraham, Rithambara Ramachandran, Stephen H Tsang, Donald C Hood.   

Abstract

PURPOSE: The aims of this retrospective study were to compare the results of recommended screening tests for hydroxychloroquine-related retinal toxicity and analyze disparities between the structural and functional findings.
METHODS: Thirty-four patients (31 women and 3 men) were included in the study. All were evaluated with standard automated perimetry using the 10-2 and/or 24-2 visual field program (Zeiss, Meditec), multifocal electroretinography (mfERG), spectral-domain optical coherence tomography (SD-OCT), and short-wavelength fundus autofluorescent imaging (SW-FAF). The results for the right eye from each patient were analyzed. Visual fields were classified as normal or abnormal based on pattern deviation plots, and mfERGs based on a comparison of R5 ring ratios to values from 20 controls. The SW-FAF images were examined for areas/rings of abnormal hypo- and/or hyperautofluorescence, and the SD-OCT line scans were classified as abnormal based on visual inspection and thickness measurements of the outer segment plus retinal pigment epithelial layer and total receptor layers compared to mean thicknesses from 35 controls.
RESULTS: Fifteen patients had abnormal results on at least one test; however, only two patients had abnormal results on all four tests. Excluding SW-FAF, seven of the 15 had abnormal visual fields, mfERG ring ratios, and SD-OCTs. The remaining eight had either abnormal mfERGs and/or visual fields and normal SD-OCTs. We found no evidence of abnormal SD-OCTs in the presence of normal mfERG and visual field results.
CONCLUSIONS: The findings suggest that functional deficits precede structural changes seen on SD-OCT in these patients.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25502494      PMCID: PMC4303510          DOI: 10.1007/s10633-014-9474-6

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  21 in total

1.  Quantitative measurements of autofluorescence with the scanning laser ophthalmoscope.

Authors:  François Delori; Jonathan P Greenberg; Russell L Woods; Jörg Fischer; Tobias Duncker; Janet Sparrow; R Theodore Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-12-09       Impact factor: 4.799

2.  Reliability of a computer-aided manual procedure for segmenting optical coherence tomography scans.

Authors:  Donald C Hood; Jungsuk Cho; Ali S Raza; Elizabeth A Dale; Min Wang
Journal:  Optom Vis Sci       Date:  2011-01       Impact factor: 1.973

3.  Fundus autofluorescence and mfERG for early detection of retinal alterations in patients using chloroquine/hydroxychloroquine.

Authors:  Ulrich Kellner; Agnes B Renner; Hilmar Tillack
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-08       Impact factor: 4.799

4.  Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy.

Authors:  Michel Michaelides; Niamh B Stover; Peter J Francis; Richard G Weleber
Journal:  Arch Ophthalmol       Date:  2011-01

Review 5.  ISCEV standard for clinical multifocal electroretinography (mfERG) (2011 edition).

Authors:  Donald C Hood; Michael Bach; Mitchell Brigell; David Keating; Mineo Kondo; Jonathan S Lyons; Michael F Marmor; Daphne L McCulloch; Anja M Palmowski-Wolfe
Journal:  Doc Ophthalmol       Date:  2011-10-30       Impact factor: 2.379

6.  Multifocal electroretinographic evaluation of long-term hydroxychloroquine users.

Authors:  Raj K Maturi; Minzhong Yu; Richard G Weleber
Journal:  Arch Ophthalmol       Date:  2004-07

7.  Ocular effects and safety of antimalarial agents.

Authors:  M Easterbrook
Journal:  Am J Med       Date:  1988-10-14       Impact factor: 4.965

8.  Long-term course of antimalarial maculopathy after cessation of treatment.

Authors:  M Easterbrook
Journal:  Can J Ophthalmol       Date:  1992-08       Impact factor: 1.882

9.  Thickness of receptor and post-receptor retinal layers in patients with retinitis pigmentosa measured with frequency-domain optical coherence tomography.

Authors:  Donald C Hood; Christine E Lin; Margot A Lazow; Kirsten G Locke; Xian Zhang; David G Birch
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-11-14       Impact factor: 4.799

10.  Spectral domain optical coherence tomography as an effective screening test for hydroxychloroquine retinopathy (the "flying saucer" sign).

Authors:  Eric Chen; David M Brown; Matthew S Benz; Richard H Fish; Tien P Wong; Rosa Y Kim; James C Major
Journal:  Clin Ophthalmol       Date:  2010-10-21
View more
  5 in total

1.  Photoreceptor dysfunction in early and intermediate age-related macular degeneration assessed with mfERG and spectral domain OCT.

Authors:  Shasha Yang; Chengguo Zuo; Hui Xiao; Lan Mi; Guangwei Luo; Xiaoyu Xu; Xing Liu
Journal:  Doc Ophthalmol       Date:  2016-01-11       Impact factor: 2.379

2.  Unusual Fundus Autofluorescence Appearance in a Patient with Hydroxychloroquine Retinal Toxicity.

Authors:  Sleiman Abou-Ltaif
Journal:  Case Rep Ophthalmol       Date:  2015-06-06

3.  A novel 5-ring multifocal electroretinography stimulus for detecting hydroxychloroquine retinal toxicity.

Authors:  Adrian Tsang; Pushpinder Kanda; Chloe Gottlieb; Gianni Virgili; Lynca Kantungane; Stuart Coupland
Journal:  Doc Ophthalmol       Date:  2021-11-11       Impact factor: 1.854

4.  Spectral-Domain Optical Coherence Tomography Is More Sensitive for Hydroxychloroquine-Related Structural Abnormalities Than Short-Wavelength and Near-Infrared Autofluorescence.

Authors:  Ruben Jauregui; Rait Parmann; Yan Nuzbrokh; Stephen H Tsang; Janet R Sparrow
Journal:  Transl Vis Sci Technol       Date:  2020-08-05       Impact factor: 3.283

5.  Quantitative Fundus Autofluorescence in HCQ Retinopathy.

Authors:  Vivienne C Greenstein; Jose Ronaldo Lima de Carvalho; Rait Parmann; Luz Amaro-Quireza; Winston Lee; Donald C Hood; Stephen H Tsang; Janet R Sparrow
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-09-01       Impact factor: 4.799

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.